Ablynx, a Sanofi company
Overview
Ablynx, a Sanofi company, is a biopharmaceutical company that specializes in the development of Nanobodies, a novel class of therapeutic proteins derived from single-domain antibody fragments. As a subsidiary of Sanofi, Ablynx expands its capabilities in developing treatments for inflammatory diseases, hematology, and oncology.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Ablynx, a Sanofi company in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Ablynx, a Sanofi company? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.